TCL Archive Phase III Trial Retrospective Analysis Finds Talimogene Laherparepvec Reduced Tumors March 28, 2014
TCL Archive DCCR Gets Go Ahead For New Community Clinical Oncology Program, $600,000 – $1 Million a Year May 12, 1978